Pernix therapeutics holdings, inc. (PTX)
Income statement / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net revenues

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

144,465

-

-

-

138,129

140,856

157,052

164,199

174,430

175,850

183,315

166,179

136,584

121,747

91,838

78,654

81,846

84,872

79,080

71,284

0

-

0

0

-

-

-

-

-

-

-

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and operating expenses:
Cost of product sales

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

46,957

34,221

0

0

0

Cost of product sales

-

-

-

-

-

-

-

43,320

48,254

49,450

51,050

51,408

53,391

54,019

49,605

47,965

42,058

38,966

40,748

43,870

41,327

39,515

31,763

23,377

23,713

23,638

23,655

20,921

14,479

7,469

0

0

0

Selling, general and administrative expense

84,694

73,048

73,809

76,801

84,738

86,685

93,159

98,834

98,294

103,540

102,905

97,421

91,975

78,636

67,001

60,158

64,515

62,175

62,094

62,551

50,110

48,207

42,702

35,452

30,905

26,610

23,767

22,157

19,060

16,306

0

0

0

Research and development expense

1,612

187

263

787

1,649

3,262

5,679

6,079

7,724

9,192

8,163

8,229

7,978

5,088

3,963

3,938

2,769

3,112

4,559

4,798

3,852

3,552

1,869

732

716

530

886

922

970

1,139

0

0

0

Loss on sale of PML (including impairment charge)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,659

6,659

6,672

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Loss from the operations of the joint venture with SEEK

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

691

591

0

0

0

Royalties expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

582

550

0

0

0

Depreciation and amortization expense

31,926

47,749

64,534

73,216

75,688

78,174

81,021

86,138

93,629

98,662

99,926

94,695

85,172

69,598

49,241

32,999

16,576

8,734

9,042

8,676

7,299

5,868

4,387

3,201

2,932

2,650

2,447

2,302

1,990

1,577

0

0

0

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-1,246

-362

-1,128

-1,045

0

0

0

-

-

-

-5,640

-138

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from disposal and impairments of assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from disposal and impairments of assets

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

Gain from legal settlement

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

1,266

1,171

817

88

44

2,418

2,387

2,287

2,221

-60

-168

1,137

1,193

1,197

1,305

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

176,698

168,470

189,896

202,527

243,234

262,649

274,742

281,184

285,191

291,089

280,588

277,104

222,561

194,973

171,559

151,961

151,410

138,488

141,735

138,728

102,589

97,147

80,722

63,002

58,632

53,927

51,600

47,498

37,776

27,634

0

0

0

Income (loss) from operations

-48,774

-37,233

-45,431

-56,459

-108,534

-126,950

-136,613

-140,328

-114,345

-113,096

-106,158

-101,254

-53,040

-42,588

-34,975

-30,214

-59,571

-59,833

-59,889

-53,856

-23,446

-18,164

-11,813

-1,689

5,885

9,521

13,393

13,107

9,180

6,586

0

0

0

Other income (expense):
Interest income

-

-

-

-

-

-

-

-

-

-

-

157

196

271

317

353

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

0

0

0

-

0

0

0

-

36,277

37,107

37,903

38,277

38,825

34,591

27,192

19,150

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

124

152

382

47

2,153

1,898

1,787

8,935

6,829

17,565

26,109

19,315

19,230

8,703

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from exchange of debt

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency transaction gain

0

0

-

-

0

0

-

99

-484

-515

-444

-582

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of put right

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,361

0

0

0

-

-

0

0

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Gain from bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,527

-2,736

-1,131

-95

-101

-146

-181

-171

-121

-79

0

0

0

Gain on sale of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

Cost of inducement

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-36,735

-20,601

-20,475

-20,309

-21,726

-36,134

-36,044

-28,823

-29,928

-21,122

-32,749

-39,999

-40,011

-45,117

-26,875

-18,797

3,829

6,757

9,134

7,464

-5,233

-2,819

-2,989

-95

0

0

0

-

-

-

-

-

-

Income (loss) before income tax expense

-85,509

-57,834

-65,906

-76,768

-130,260

-163,084

-172,657

-169,151

-144,273

-134,218

-138,907

-141,253

-93,051

-87,705

-61,850

-49,011

-55,742

-53,076

-50,755

-46,392

-28,679

-20,984

-14,803

-1,784

0

0

0

-

-

-

-

-

-

Total other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,219

0

0

0

-

Income before income taxes and non-controlling interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Income tax expense

360

326

357

373

535

509

459

439

20,906

15,263

11,670

7,062

-18,583

-12,286

-12,432

-13,725

-22,051

-25,253

-23,489

-20,757

-7,870

-5,727

-4,291

-374

1,919

3,245

4,649

4,589

3,361

2,641

0

0

0

Net income (loss)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Adjust: Net loss attributable to noncontrolling interests

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net income (loss) attributable to common stockholders

-76,365

-58,160

-66,263

-77,141

-130,795

-163,593

-173,116

-169,590

-165,179

-149,481

-150,577

-148,315

-74,468

-75,419

-49,418

-35,286

-33,691

-27,823

-27,266

-25,635

-20,809

-15,257

-10,512

-1,410

3,865

6,130

8,563

8,347

6,857

5,029

0

0

0

Net income (loss) per common share attributable to common stockholders:
Unrealized gain during period, net of tax of $0 and $0, respectively

-

0

0

-

-

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized Gain (loss) during period, net of tax of $0 and $0, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-702

-1,102

-294

-586

1,886

0

0

0

-

-

0

0

-

-

Reclassification adjustment for net gains included in net loss, net of tax of $0, $0 and ($1,332), respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-

-58,105

-66,190

-

-

-163,648

-173,189

-169,669

0

0

0

-

-

-

-

-

-

-

-

-28,610

-24,185

-17,824

-11,098

476

7,241

8,697

10,676

9,436

0

0

0

-

-

Basic

-0.89

-1.13

-1.57

-2.68

0.57

-2.16

-2.94

-9.77

-2.99

-4.67

-4.24

-24.81

-1.76

-0.62

-0.62

-0.20

-0.31

-0.16

-0.26

-0.16

-0.16

-0.15

-0.23

-0.06

-0.01

-0.03

0.05

0.16

0.08

0.07

0.04

0.10

0.01

Diluted

-0.89

-1.13

-1.57

-2.53

0.42

-2.16

-2.94

-9.77

-2.99

-4.67

-4.24

-24.81

-1.76

-0.62

-0.62

-0.20

-0.31

-0.16

-0.26

-0.16

-0.16

-0.15

-0.23

-0.05

-0.01

-0.03

0.04

0.15

0.08

0.07

0.04

0.10

0.01

Weighted-average common shares outstanding:
Basic

13,301

11,913

11,869

11,675

11,117

10,016

10,016

9,685

8,842

6,669

6,112

-75,617

6,097

52,399

38,453

75,497

38,121

37,828

37

73,571

37

37,114

35,052

-83,168

29,069

28,291

25,921

25,770

24,841

22,698

22,652

24,389

24,557

Diluted

13,301

11,913

11,869

6,272

16,520

10,016

10,016

9,685

8,842

6,669

6,112

-75,617

6,097

52,399

38,453

75,497

38,121

37,828

37

73,571

37

37,114

35,052

-83,721

29,069

28,291

26,473

26,509

25,147

23,043

23,141

24,416

24,608